{"ticker": {"uuid": "fb299ad0-2d20-40e8-ae93-dd6e5a6b24fc", "symbol": "PRQR", "name": "ProQR Therapeutics BV", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "FY2028 Earnings Estimate for PRQR Issued By HC Wainwright", "summary": "HC Wainwright has revised its FY2028 earnings per share estimate for ProQR Therapeutics (NASDAQ:PRQR) to a loss of $0.37, a reduction from its prior forecast of a $0.27 loss, while maintaining a \"Buy\" rating and an $8.00 price target. The biopharmaceutical company recently reported a narrower-than-expected quarterly loss of $0.09 per share and revenue of $10 million, significantly beating analyst estimates. Analyst sentiment generally remains positive with a \"Moderate Buy\" consensus, and company insiders have recently purchased a substantial amount of shares.", "url": "https://www.marketbeat.com/instant-alerts/estimates-fy2028-earnings-estimate-for-prqr-issued-by-hc-wainwright-2026-10-05", "source_link": "https://www.marketbeat.com/instant-alerts/estimates-fy2028-earnings-estimate-for-prqr-issued-by-hc-wainwright-2026-10-05", "source_link_is_lookup": false, "source_name": "MarketBeat", "published_at": "2026-10-05T05:28:09", "published_display": "05 Oct 2026 05:28", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 46, "tone_signals": ["Negative financial language"], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.037069, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 26.0, "age_days": 9.7, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Press Releases about ProQR Therapeutics N.V. - Ordinary Shares (Nasdaq:PRQR)", "summary": "This article compiles various press releases from ProQR Therapeutics N.V. (Nasdaq: PRQR) covering a range of corporate and clinical updates. Key announcements include leadership appointments, initiation of clinical trials for AX-0811, positive Phase 1 data for AX-0810, financial results, and participation in investor conferences. The updates highlight the company's progress in advancing its proprietary ADAR-mediated Axiomer\u2122 RNA editing technology platform for transformative RNA therapies.", "url": "https://www.financialcontent.com/quote/NQ:PRQR/pressReleases", "source_link": "https://www.financialcontent.com/quote/NQ:PRQR/pressReleases", "source_link_is_lookup": false, "source_name": "FinancialContent", "published_at": "2026-10-03T07:32:59", "published_display": "03 Oct 2026 07:32", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": ["Positive financial language"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.00127, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 1.8, "age_days": 11.6, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "ProQR Therapeutics N.V. - Ordinary Shares (PRQR) Stock Price, News, Quote & History", "summary": "ProQR Therapeutics N.V. (PRQR) is a biotechnology company focused on developing RNA-based therapies for genetic disorders. The article provides current stock information, including a last price of $1.6350, and highlights recent news such as the first human validation of its RNA editing platform in liver disease and new executive appointments. It also details past press releases regarding clinical trials, financial results, and investor conferences.", "url": "https://www.financialcontent.com/quote/NQ:PRQR", "source_link": "https://www.financialcontent.com/quote/NQ:PRQR", "source_link_is_lookup": false, "source_name": "FinancialContent", "published_at": "2026-10-02T14:31:52", "published_display": "02 Oct 2026 14:31", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000993, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 1.4, "age_days": 12.3, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "ProQR Reports First Human Validation of RNA Editing Platform in Liver Disease", "summary": "ProQR Therapeutics announced the first human validation of its RNA-editing platform for liver disease, showing dose-dependent target engagement for its AX-0810 candidate. The treatment, aimed at cholestatic liver diseases like pediatric biliary atresia, demonstrated no serious adverse events and increased plasma bile acids. ProQR expects data from its next-generation candidate, AX-0811, in early 2027, which is designed for greater potency and durability.", "url": "https://finance.yahoo.com/healthcare/articles/proqr-reports-first-human-validation-080203070.html", "source_link": "https://finance.yahoo.com/healthcare/articles/proqr-reports-first-human-validation-080203070.html", "source_link_is_lookup": false, "source_name": "MarketBeat", "published_at": "2026-10-02T08:02:03+00:00", "published_display": "02 Oct 2026 08:02", "source_kind": "publisher", "company_focus": 0.86, "company_focus_pct": 86, "company_focus_label": "Company discussed", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.004057, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 5.4, "age_days": 12.6, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 2, "topics": ["Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "ProQR Therapeutics N.V. (PRQR) Shareholder/Analyst Call - Slideshow (NASDAQ:PRQR) 2026-09-30", "summary": "ProQR Therapeutics N.V. (PRQR) released a slide deck for a shareholder/analyst call held on September 30, 2026. The article highlights that the content was published in conjunction with this event and was prepared by Seeking Alpha's transcripts team.", "url": "https://seekingalpha.com/article/4951203-proqr-therapeutics-n-v-prqr-shareholder-analyst-call-slideshow", "source_link": "https://seekingalpha.com/article/4951203-proqr-therapeutics-n-v-prqr-shareholder-analyst-call-slideshow", "source_link_is_lookup": false, "source_name": "Seeking Alpha", "published_at": "2026-10-01T17:31:52", "published_display": "01 Oct 2026 17:31", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.004853, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 4.7, "age_days": 13.2, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Finance", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "ProQR Therapeutics' (PRQR) \"Buy\" Rating Reiterated at Chardan Capital", "summary": "Chardan Capital has reiterated its \"buy\" rating for ProQR Therapeutics (NASDAQ:PRQR), setting a $3.00 price target that suggests an 80.72% upside. Other analysts have also issued ratings, contributing to an average \"Moderate Buy\" rating and an average target price of $7.60 for the biopharmaceutical company. Recent insider activity shows significant share purchases by the company's director and CEO.", "url": "https://www.marketbeat.com/instant-alerts/analyst-proqr-therapeutics-prqr-buy-rating-reiterated-at-chardan-capital-2026-10-01", "source_link": "https://www.marketbeat.com/instant-alerts/analyst-proqr-therapeutics-prqr-buy-rating-reiterated-at-chardan-capital-2026-10-01", "source_link_is_lookup": false, "source_name": "MarketBeat", "published_at": "2026-10-01T12:31:45", "published_display": "01 Oct 2026 12:31", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": ["Positive financial language"], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.004395, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 4.5, "age_days": 13.4, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "HC Wainwright Cuts ProQR Therapeutics (NASDAQ:PRQR) Price Target to $8.00", "summary": "HC Wainwright has lowered its price target for ProQR Therapeutics (NASDAQ:PRQR) to $8.00 while maintaining a \"buy\" rating, indicating a potential upside of 381.93%. Other analysts have also issued reports on the biopharmaceutical company, resulting in an average rating of \"Moderate Buy\" and an average price target of $7.60. The company recently reported better-than-expected earnings and saw significant insider buying.", "url": "https://www.marketbeat.com/instant-alerts/analyst-proqr-therapeutics-nasdaq-prqr-stock-price-target-lowered-at-hc-wainwright-2026-10-01", "source_link": "https://www.marketbeat.com/instant-alerts/analyst-proqr-therapeutics-nasdaq-prqr-stock-price-target-lowered-at-hc-wainwright-2026-10-01", "source_link_is_lookup": false, "source_name": "MarketBeat", "published_at": "2026-10-01T12:31:45", "published_display": "01 Oct 2026 12:31", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "negative", "sentiment_pct": 44, "tone_signals": ["Analyst downgrade"], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.006089, "evidence_share": 100.0, "evidence_share_display": "100", "freshness_pct": 4.5, "age_days": 13.4, "influence_label": "Low", "evidence_strength": 34, "duplicate_count": 1, "topics": ["Earnings", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": true}, {"title": "H.C. Wainwright cuts ProQR stock price target on execution risks By Investing.com", "summary": "H.C. Wainwright has reduced its price target for ProQR Therapeutics N.V. (NASDAQ:PRQR) to $8.00 from $12.00, citing execution and regulatory risks, despite maintaining a Buy rating. The biotech company, currently trading at $1.66, is burning through cash but holds more cash than debt and has liquid assets exceeding short-term obligations. ProQR recently shared positive initial safety data for its AX-0810 drug, and analysts continue to show interest in its innovative therapies.", "url": "https://ng.investing.com/news/stock-market-news/hc-wainwright-cuts-proqr-stock-price-target-on-execution-risks-93CH-2717885", "source_link": "https://ng.investing.com/news/stock-market-news/hc-wainwright-cuts-proqr-stock-price-target-on-execution-risks-93CH-2717885", "source_link_is_lookup": false, "source_name": "Investing.com Nigeria", "published_at": "2026-10-01T12:22:34", "published_display": "01 Oct 2026 12:22", "source_kind": "publisher", "company_focus": 0.86, "company_focus_pct": 86, "company_focus_label": "Company discussed", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": ["Buy Rating", "Analyst downgrade"], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.005805, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 4.5, "age_days": 13.4, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "ProQR Therapeutics NV Investor and Analyst Event: NTCP Modulation in Biliary Atresia via Liver-Targeted RNA Editing Call Transcript", "summary": "This document is a call transcript from a ProQR Therapeutics NV Investor and Analyst Event focusing on NTCP modulation in biliary atresia through liver-targeted RNA editing. The event includes a formal presentation and a Q&A session, with an emphasis on forward-looking statements and associated risks. Sarah Keeley, VP of Investor Relations and Corporate Communications, initiated the call.", "url": "https://www.gurufocus.com/stock/PRQR/transcripts/9104093", "source_link": "https://www.gurufocus.com/stock/PRQR/transcripts/9104093", "source_link_is_lookup": false, "source_name": "GuruFocus", "published_at": "2026-09-30T13:31:45", "published_display": "30 Sep 2026 13:31", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.003177, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 3.6, "age_days": 14.4, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Price to sales forward of ProQR Therapeutics N.V. \u2013 DUS:0PQ", "summary": "The article focuses on the \"Price to sales forward\" financial metric for ProQR Therapeutics N.V. (DUS:0PQ), listed on the Dusseldorf Stock Exchange. It appears to be a financial data snippet or a specific page from a financial analysis platform like TradingView, showing a value for this metric over a certain period. The content primarily lists various navigation and product options available on the platform, suggesting it's part of a larger financial information portal.", "url": "https://www.tradingview.com/symbols/DUS-0PQ/financials-statistics-and-ratios/price-sales-fwd", "source_link": "https://www.tradingview.com/symbols/DUS-0PQ/financials-statistics-and-ratios/price-sales-fwd", "source_link_is_lookup": false, "source_name": "TradingView", "published_at": "2026-09-27T18:23:40", "published_display": "27 Sep 2026 18:23", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000159, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.3, "age_days": 17.2, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Finance", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Hugging Face co-founder joins ProQR (PRQR) to drive AI drug discovery", "summary": "ProQR Therapeutics N.V. (PRQR) has appointed Chris Hart, PhD, as Chief Data and AI Officer and welcomed Thomas Wolf, PhD, co-founder of Hugging Face, as a strategic AI advisor to its Board. These appointments aim to integrate AI further into the company's drug discovery and development processes using its Axiomer RNA editing platform. ProQR anticipates up to five clinical data readouts across four development programs in the next 12 months, including target-engagement data for its AI-discovered drug AX-0811 expected in early January 2027.", "url": "https://www.stocktitan.net/sec-filings/PRQR/6-k-pro-qr-therapeutics-n-v-current-report-foreign-issuer-c113b623d814.html", "source_link": "https://www.stocktitan.net/sec-filings/PRQR/6-k-pro-qr-therapeutics-n-v-current-report-foreign-issuer-c113b623d814.html", "source_link_is_lookup": false, "source_name": "Stock Titan", "published_at": "2026-09-23T12:13:54", "published_display": "23 Sep 2026 12:13", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 4.2e-05, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.1, "age_days": 21.4, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Life Sciences", "Technology"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "ProQR Therapeutics N.V. (NASDAQ:PRQR) Receives Average Rating of \"Moderate Buy\" from Brokerages", "summary": "ProQR Therapeutics (NASDAQ:PRQR) has received an average \"Moderate Buy\" rating from eight brokerages, with an average 12-month price target of $7.50, significantly higher than its current $1.90 opening price. The company surpassed quarterly earnings estimates, reporting a negative EPS of $0.09 against an expected negative $0.13, and revenue of $10 million against an anticipated $4.56 million. Insider transactions show executives and directors purchased 600,000 shares worth $988,500 in the last 90 days.", "url": "https://www.marketbeat.com/instant-alerts/consensus-proqr-therapeutics-nv-nasdaq-prqr-receives-average-rating-of-moderate-buy-from-brokerages-2026-09-23", "source_link": "https://www.marketbeat.com/instant-alerts/consensus-proqr-therapeutics-nv-nasdaq-prqr-receives-average-rating-of-moderate-buy-from-brokerages-2026-09-23", "source_link_is_lookup": false, "source_name": "MarketBeat", "published_at": "2026-09-23T06:13:54", "published_display": "23 Sep 2026 06:13", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 53, "tone_signals": ["Beat expectations"], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.006964, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 4.9, "age_days": 21.7, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Finance", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "ProQR Therapeutics (Nasdaq:PRQR) - Stock Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxNdUpMMmswRDNqQ240ZzBuaGZndS1MQ2dZODA2Z1JkeFRhanlHclhuelpPSWpCQzVsNEZrRmQtSkFVbHlCQmYycF92YmY1T2hNb2xfWjZWTkFBa0ZEMWpkQk5Uc3hoWGFyMDIxZXp5MHF6YjZJQ1NzV01XdjZkbjQ1R0pJb3BiWk9Gbm1UUHZVTQ?oc=5", "source_link": "https://news.google.com/rss/articles/CBMijwFBVV95cUxNdUpMMmswRDNqQ240ZzBuaGZndS1MQ2dZODA2Z1JkeFRhanlHclhuelpPSWpCQzVsNEZrRmQtSkFVbHlCQmYycF92YmY1T2hNb2xfWjZWTkFBa0ZEMWpkQk5Uc3hoWGFyMDIxZXp5MHF6YjZJQ1NzV01XdjZkbjQ1R0pJb3BiWk9Gbm1UUHZVTQ?oc=5", "source_link_is_lookup": false, "source_name": "Simply Wall Street", "published_at": "2026-09-21T07:00:00+00:00", "published_display": "21 Sep 2026 07:00", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 1.7e-05, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.0, "age_days": 23.7, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": false}], "by_tier": {"direct": [{"title": "FY2028 Earnings Estimate for PRQR Issued By HC Wainwright", "summary": "HC Wainwright has revised its FY2028 earnings per share estimate for ProQR Therapeutics (NASDAQ:PRQR) to a loss of $0.37, a reduction from its prior forecast of a $0.27 loss, while maintaining a \"Buy\" rating and an $8.00 price target. The biopharmaceutical company recently reported a narrower-than-expected quarterly loss of $0.09 per share and revenue of $10 million, significantly beating analyst estimates. Analyst sentiment generally remains positive with a \"Moderate Buy\" consensus, and company insiders have recently purchased a substantial amount of shares.", "url": "https://www.marketbeat.com/instant-alerts/estimates-fy2028-earnings-estimate-for-prqr-issued-by-hc-wainwright-2026-10-05", "source_link": "https://www.marketbeat.com/instant-alerts/estimates-fy2028-earnings-estimate-for-prqr-issued-by-hc-wainwright-2026-10-05", "source_link_is_lookup": false, "source_name": "MarketBeat", "published_at": "2026-10-05T05:28:09", "published_display": "05 Oct 2026 05:28", "provider": "alphavantage", "providers": ["alphavantage", "archive"], "provider_symbol": "", "provider_symbols": ["PRQR", "PRQR.ARCHIVE"], "target_provider_symbol": "PRQR", "cross_listing": false, "source_names": ["MarketBeat"], "source_kind": "publisher", "story_key": "2c6cc410576cab76c18f091b36bb8b2c166d257df2dddcd1a24d36af2e42dcc4", "target_scope": "FY2028 Earnings Estimate for PRQR Issued By HC Wainwright HC Wainwright has revised its FY2028 earnings per share estimate for ProQR Therapeutics (NASDAQ:PRQR) to a loss of $0.37, a reduction from its prior forecast of a $0.27 loss,", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.53, "provider_directional_mass": 0.2937, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 46, "tone_signals": ["Negative financial language"], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.037069, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 26.0, "age_days": 9.7, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Press Releases about ProQR Therapeutics N.V. - Ordinary Shares (Nasdaq:PRQR)", "summary": "This article compiles various press releases from ProQR Therapeutics N.V. (Nasdaq: PRQR) covering a range of corporate and clinical updates. Key announcements include leadership appointments, initiation of clinical trials for AX-0811, positive Phase 1 data for AX-0810, financial results, and participation in investor conferences. The updates highlight the company's progress in advancing its proprietary ADAR-mediated Axiomer\u2122 RNA editing technology platform for transformative RNA therapies.", "url": "https://www.financialcontent.com/quote/NQ:PRQR/pressReleases", "source_link": "https://www.financialcontent.com/quote/NQ:PRQR/pressReleases", "source_link_is_lookup": false, "source_name": "FinancialContent", "published_at": "2026-10-03T07:32:59", "published_display": "03 Oct 2026 07:32", "provider": "alphavantage", "providers": ["alphavantage", "archive"], "provider_symbol": "", "provider_symbols": ["PRQR", "PRQR.ARCHIVE"], "target_provider_symbol": "PRQR", "cross_listing": false, "source_names": ["FinancialContent"], "source_kind": "publisher", "story_key": "5f8e4e92d13c46406d421e3d6a041f1fd4405822182590f9fd148e1b09895be3", "target_scope": "Press Releases about ProQR Therapeutics N.V. - Ordinary Shares (Nasdaq:PRQR) This article compiles various press releases from ProQR Therapeutics N.V. (Nasdaq: PRQR) covering a range of corporate and clinical updates.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": 0.3189, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.00127, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 1.8, "age_days": 11.6, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "ProQR Therapeutics N.V. - Ordinary Shares (PRQR) Stock Price, News, Quote & History", "summary": "ProQR Therapeutics N.V. (PRQR) is a biotechnology company focused on developing RNA-based therapies for genetic disorders. The article provides current stock information, including a last price of $1.6350, and highlights recent news such as the first human validation of its RNA editing platform in liver disease and new executive appointments. It also details past press releases regarding clinical trials, financial results, and investor conferences.", "url": "https://www.financialcontent.com/quote/NQ:PRQR", "source_link": "https://www.financialcontent.com/quote/NQ:PRQR", "source_link_is_lookup": false, "source_name": "FinancialContent", "published_at": "2026-10-02T14:31:52", "published_display": "02 Oct 2026 14:31", "provider": "alphavantage", "providers": ["alphavantage", "archive"], "provider_symbol": "", "provider_symbols": ["PRQR", "PRQR.ARCHIVE"], "target_provider_symbol": "PRQR", "cross_listing": false, "source_names": ["FinancialContent"], "source_kind": "publisher", "story_key": "6bc4a85679b106c35cc394bccf1e6cca3abfa7b1be51cbd0abdf11fd8146fc85", "target_scope": "ProQR Therapeutics N.V. - Ordinary Shares (PRQR) Stock Price, News, Quote & History ProQR Therapeutics N.V. (PRQR) is a biotechnology company focused on developing RNA-based therapies for genetic disorders.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": 0.3439, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000993, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 1.4, "age_days": 12.3, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "ProQR Reports First Human Validation of RNA Editing Platform in Liver Disease", "summary": "ProQR Therapeutics announced the first human validation of its RNA-editing platform for liver disease, showing dose-dependent target engagement for its AX-0810 candidate. The treatment, aimed at cholestatic liver diseases like pediatric biliary atresia, demonstrated no serious adverse events and increased plasma bile acids. ProQR expects data from its next-generation candidate, AX-0811, in early 2027, which is designed for greater potency and durability.", "url": "https://finance.yahoo.com/healthcare/articles/proqr-reports-first-human-validation-080203070.html", "source_link": "https://finance.yahoo.com/healthcare/articles/proqr-reports-first-human-validation-080203070.html", "source_link_is_lookup": false, "source_name": "MarketBeat", "published_at": "2026-10-02T08:02:03+00:00", "published_display": "02 Oct 2026 08:02", "provider": "yfinance", "providers": ["alphavantage", "archive", "yfinance"], "provider_symbol": "", "provider_symbols": ["PRQR", "PRQR.ARCHIVE"], "target_provider_symbol": "PRQR", "cross_listing": false, "source_names": ["Market source", "MarketBeat"], "source_kind": "publisher", "story_key": "0d832d9826d56db310895f69f0dfcdc8a5ccf430266579d3835e7e91ae6c2c9c", "target_scope": "ProQR Therapeutics announced the first human validation of its RNA-editing platform for liver disease, showing dose-dependent target engagement for its AX-0810 candidate.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": null, "relevance_score": 1.0, "company_focus": 0.86, "company_focus_pct": 86, "company_focus_label": "Company discussed", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.004057, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 5.4, "age_days": 12.6, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 2, "topics": ["Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "ProQR Therapeutics N.V. (PRQR) Shareholder/Analyst Call - Slideshow (NASDAQ:PRQR) 2026-09-30", "summary": "ProQR Therapeutics N.V. (PRQR) released a slide deck for a shareholder/analyst call held on September 30, 2026. The article highlights that the content was published in conjunction with this event and was prepared by Seeking Alpha's transcripts team.", "url": "https://seekingalpha.com/article/4951203-proqr-therapeutics-n-v-prqr-shareholder-analyst-call-slideshow", "source_link": "https://seekingalpha.com/article/4951203-proqr-therapeutics-n-v-prqr-shareholder-analyst-call-slideshow", "source_link_is_lookup": false, "source_name": "Seeking Alpha", "published_at": "2026-10-01T17:31:52", "published_display": "01 Oct 2026 17:31", "provider": "alphavantage", "providers": ["alphavantage", "archive"], "provider_symbol": "", "provider_symbols": ["PRQR", "PRQR.ARCHIVE"], "target_provider_symbol": "PRQR", "cross_listing": false, "source_names": ["Seeking Alpha"], "source_kind": "publisher", "story_key": "03d2d0f7971bab374e0a6ab3e232edd6942e383713625b721fb3fc1e704b1f23", "target_scope": "ProQR Therapeutics N.V. (PRQR) Shareholder/Analyst Call - Slideshow (NASDAQ:PRQR) 2026-09-30 ProQR Therapeutics N.V. (PRQR) released a slide deck for a shareholder/analyst call held on September 30, 2026.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": 0.0431, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.004853, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 4.7, "age_days": 13.2, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Finance", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "ProQR Therapeutics' (PRQR) \"Buy\" Rating Reiterated at Chardan Capital", "summary": "Chardan Capital has reiterated its \"buy\" rating for ProQR Therapeutics (NASDAQ:PRQR), setting a $3.00 price target that suggests an 80.72% upside. Other analysts have also issued ratings, contributing to an average \"Moderate Buy\" rating and an average target price of $7.60 for the biopharmaceutical company. Recent insider activity shows significant share purchases by the company's director and CEO.", "url": "https://www.marketbeat.com/instant-alerts/analyst-proqr-therapeutics-prqr-buy-rating-reiterated-at-chardan-capital-2026-10-01", "source_link": "https://www.marketbeat.com/instant-alerts/analyst-proqr-therapeutics-prqr-buy-rating-reiterated-at-chardan-capital-2026-10-01", "source_link_is_lookup": false, "source_name": "MarketBeat", "published_at": "2026-10-01T12:31:45", "published_display": "01 Oct 2026 12:31", "provider": "alphavantage", "providers": ["alphavantage", "archive"], "provider_symbol": "", "provider_symbols": ["PRQR", "PRQR.ARCHIVE"], "target_provider_symbol": "PRQR", "cross_listing": false, "source_names": ["MarketBeat"], "source_kind": "publisher", "story_key": "e7dd8d243137479497e5bbc5a90c4f18cebacc4f16088058847a1bdcac6e7af8", "target_scope": "ProQR Therapeutics' (PRQR) \"Buy\" Rating Reiterated at Chardan Capital Chardan Capital has reiterated its \"buy\" rating for ProQR Therapeutics (NASDAQ:PRQR), setting a $3.00 price target that suggests an 80.72% upside.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.51, "provider_directional_mass": 0.4008, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": ["Positive financial language"], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.004395, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 4.5, "age_days": 13.4, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "HC Wainwright Cuts ProQR Therapeutics (NASDAQ:PRQR) Price Target to $8.00", "summary": "HC Wainwright has lowered its price target for ProQR Therapeutics (NASDAQ:PRQR) to $8.00 while maintaining a \"buy\" rating, indicating a potential upside of 381.93%. Other analysts have also issued reports on the biopharmaceutical company, resulting in an average rating of \"Moderate Buy\" and an average price target of $7.60. The company recently reported better-than-expected earnings and saw significant insider buying.", "url": "https://www.marketbeat.com/instant-alerts/analyst-proqr-therapeutics-nasdaq-prqr-stock-price-target-lowered-at-hc-wainwright-2026-10-01", "source_link": "https://www.marketbeat.com/instant-alerts/analyst-proqr-therapeutics-nasdaq-prqr-stock-price-target-lowered-at-hc-wainwright-2026-10-01", "source_link_is_lookup": false, "source_name": "MarketBeat", "published_at": "2026-10-01T12:31:45", "published_display": "01 Oct 2026 12:31", "provider": "alphavantage", "providers": ["alphavantage", "archive"], "provider_symbol": "", "provider_symbols": ["PRQR", "PRQR.ARCHIVE"], "target_provider_symbol": "PRQR", "cross_listing": false, "source_names": ["MarketBeat"], "source_kind": "publisher", "story_key": "0582ad9c47c0b316e0c88ed65c9bcd463338b206d293b0bcddd18f765790b6b4", "target_scope": "HC Wainwright Cuts ProQR Therapeutics (NASDAQ:PRQR) Price Target to $8.00 HC Wainwright has lowered its price target for ProQR Therapeutics (NASDAQ:PRQR) to $8.00", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.595, "provider_directional_mass": 0.1094, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "negative", "sentiment_pct": 44, "tone_signals": ["Analyst downgrade"], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.006089, "evidence_share": 100.0, "evidence_share_display": "100", "freshness_pct": 4.5, "age_days": 13.4, "influence_label": "Low", "evidence_strength": 34, "duplicate_count": 1, "topics": ["Earnings", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": true}, {"title": "H.C. Wainwright cuts ProQR stock price target on execution risks By Investing.com", "summary": "H.C. Wainwright has reduced its price target for ProQR Therapeutics N.V. (NASDAQ:PRQR) to $8.00 from $12.00, citing execution and regulatory risks, despite maintaining a Buy rating. The biotech company, currently trading at $1.66, is burning through cash but holds more cash than debt and has liquid assets exceeding short-term obligations. ProQR recently shared positive initial safety data for its AX-0810 drug, and analysts continue to show interest in its innovative therapies.", "url": "https://ng.investing.com/news/stock-market-news/hc-wainwright-cuts-proqr-stock-price-target-on-execution-risks-93CH-2717885", "source_link": "https://ng.investing.com/news/stock-market-news/hc-wainwright-cuts-proqr-stock-price-target-on-execution-risks-93CH-2717885", "source_link_is_lookup": false, "source_name": "Investing.com Nigeria", "published_at": "2026-10-01T12:22:34", "published_display": "01 Oct 2026 12:22", "provider": "alphavantage", "providers": ["alphavantage", "archive"], "provider_symbol": "", "provider_symbols": ["PRQR", "PRQR.ARCHIVE"], "target_provider_symbol": "PRQR", "cross_listing": false, "source_names": ["Investing.com Nigeria"], "source_kind": "publisher", "story_key": "25577bc7f3d23c74dbba366f21d3efc876c9df40f012577d22638691e3743702", "target_scope": "Wainwright has reduced its price target for ProQR Therapeutics N.V. (NASDAQ:PRQR) to $8.00 from $12.00, citing execution and regulatory risks, despite maintaining a Buy rating.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.5820000000000001, "provider_directional_mass": 0.2702, "relevance_score": 1.0, "company_focus": 0.86, "company_focus_pct": 86, "company_focus_label": "Company discussed", "entity_mapped": true, "sentiment_conflict": 0.6, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": ["Buy Rating", "Analyst downgrade"], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.005805, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 4.5, "age_days": 13.4, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "ProQR Therapeutics NV Investor and Analyst Event: NTCP Modulation in Biliary Atresia via Liver-Targeted RNA Editing Call Transcript", "summary": "This document is a call transcript from a ProQR Therapeutics NV Investor and Analyst Event focusing on NTCP modulation in biliary atresia through liver-targeted RNA editing. The event includes a formal presentation and a Q&A session, with an emphasis on forward-looking statements and associated risks. Sarah Keeley, VP of Investor Relations and Corporate Communications, initiated the call.", "url": "https://www.gurufocus.com/stock/PRQR/transcripts/9104093", "source_link": "https://www.gurufocus.com/stock/PRQR/transcripts/9104093", "source_link_is_lookup": false, "source_name": "GuruFocus", "published_at": "2026-09-30T13:31:45", "published_display": "30 Sep 2026 13:31", "provider": "alphavantage", "providers": ["alphavantage", "archive"], "provider_symbol": "", "provider_symbols": ["PRQR", "PRQR.ARCHIVE"], "target_provider_symbol": "PRQR", "cross_listing": false, "source_names": ["GuruFocus"], "source_kind": "publisher", "story_key": "43ce7681053e553ae9ed4c3d68245744d0dc99bf46da9e470a239a70c9826d8a", "target_scope": "ProQR Therapeutics NV Investor and Analyst Event: NTCP Modulation in Biliary Atresia via Liver-Targeted RNA Editing Call Transcript This document is a call transcript from a ProQR Therapeutics NV Investor and Analyst Event focusing on NTCP modulation in biliary atresia through liver-targeted RNA editing.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": 0.1071, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.003177, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 3.6, "age_days": 14.4, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Price to sales forward of ProQR Therapeutics N.V. \u2013 DUS:0PQ", "summary": "The article focuses on the \"Price to sales forward\" financial metric for ProQR Therapeutics N.V. (DUS:0PQ), listed on the Dusseldorf Stock Exchange. It appears to be a financial data snippet or a specific page from a financial analysis platform like TradingView, showing a value for this metric over a certain period. The content primarily lists various navigation and product options available on the platform, suggesting it's part of a larger financial information portal.", "url": "https://www.tradingview.com/symbols/DUS-0PQ/financials-statistics-and-ratios/price-sales-fwd", "source_link": "https://www.tradingview.com/symbols/DUS-0PQ/financials-statistics-and-ratios/price-sales-fwd", "source_link_is_lookup": false, "source_name": "TradingView", "published_at": "2026-09-27T18:23:40", "published_display": "27 Sep 2026 18:23", "provider": "alphavantage", "providers": ["alphavantage", "archive"], "provider_symbol": "", "provider_symbols": ["PRQR", "PRQR.ARCHIVE"], "target_provider_symbol": "PRQR", "cross_listing": false, "source_names": ["TradingView"], "source_kind": "publisher", "story_key": "247cd88b4786559b1a199a7ee44fa193e9e10b89fefbba2f8c660f48749d26f7", "target_scope": "Price to sales forward of ProQR Therapeutics N.V. The article focuses on the \"Price to sales forward\" financial metric for ProQR Therapeutics N.V.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": 0.0326, "relevance_score": 0.78, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000159, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.3, "age_days": 17.2, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Finance", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Hugging Face co-founder joins ProQR (PRQR) to drive AI drug discovery", "summary": "ProQR Therapeutics N.V. (PRQR) has appointed Chris Hart, PhD, as Chief Data and AI Officer and welcomed Thomas Wolf, PhD, co-founder of Hugging Face, as a strategic AI advisor to its Board. These appointments aim to integrate AI further into the company's drug discovery and development processes using its Axiomer RNA editing platform. ProQR anticipates up to five clinical data readouts across four development programs in the next 12 months, including target-engagement data for its AI-discovered drug AX-0811 expected in early January 2027.", "url": "https://www.stocktitan.net/sec-filings/PRQR/6-k-pro-qr-therapeutics-n-v-current-report-foreign-issuer-c113b623d814.html", "source_link": "https://www.stocktitan.net/sec-filings/PRQR/6-k-pro-qr-therapeutics-n-v-current-report-foreign-issuer-c113b623d814.html", "source_link_is_lookup": false, "source_name": "Stock Titan", "published_at": "2026-09-23T12:13:54", "published_display": "23 Sep 2026 12:13", "provider": "alphavantage", "providers": ["alphavantage", "archive"], "provider_symbol": "", "provider_symbols": ["PRQR", "PRQR.ARCHIVE"], "target_provider_symbol": "PRQR", "cross_listing": false, "source_names": ["Stock Titan"], "source_kind": "publisher", "story_key": "eb20f15637fa5b71cfe7427524100673fcf5cbac910ac17216639ea82c4d0c3a", "target_scope": "Hugging Face co-founder joins ProQR (PRQR) to drive AI drug discovery ProQR Therapeutics N.V. (PRQR) has appointed Chris Hart, PhD, as Chief Data and AI Officer and welcomed Thomas Wolf, PhD, co-founder of Hugging Face, as a strategic AI advisor to its Board.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": 0.5285, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 4.2e-05, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.1, "age_days": 21.4, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Life Sciences", "Technology"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "ProQR Therapeutics N.V. (NASDAQ:PRQR) Receives Average Rating of \"Moderate Buy\" from Brokerages", "summary": "ProQR Therapeutics (NASDAQ:PRQR) has received an average \"Moderate Buy\" rating from eight brokerages, with an average 12-month price target of $7.50, significantly higher than its current $1.90 opening price. The company surpassed quarterly earnings estimates, reporting a negative EPS of $0.09 against an expected negative $0.13, and revenue of $10 million against an anticipated $4.56 million. Insider transactions show executives and directors purchased 600,000 shares worth $988,500 in the last 90 days.", "url": "https://www.marketbeat.com/instant-alerts/consensus-proqr-therapeutics-nv-nasdaq-prqr-receives-average-rating-of-moderate-buy-from-brokerages-2026-09-23", "source_link": "https://www.marketbeat.com/instant-alerts/consensus-proqr-therapeutics-nv-nasdaq-prqr-receives-average-rating-of-moderate-buy-from-brokerages-2026-09-23", "source_link_is_lookup": false, "source_name": "MarketBeat", "published_at": "2026-09-23T06:13:54", "published_display": "23 Sep 2026 06:13", "provider": "alphavantage", "providers": ["alphavantage", "archive"], "provider_symbol": "", "provider_symbols": ["PRQR", "PRQR.ARCHIVE"], "target_provider_symbol": "PRQR", "cross_listing": false, "source_names": ["MarketBeat"], "source_kind": "publisher", "story_key": "5fc6c5bc2e23cb15998d74f92e8cff13249660615debf6059c2aeb182ebb2d1d", "target_scope": "ProQR Therapeutics N.V. (NASDAQ:PRQR) Receives Average Rating of \"Moderate Buy\" from Brokerages ProQR Therapeutics (NASDAQ:PRQR) has received an average \"Moderate Buy\" rating from eight brokerages, with an average 12-month price target of $7.50, significantly higher than its current $1.90 opening price. but The company surpassed quarterly earnings estimates, reporting a negative EPS of $0.09 against an expected negative $0.13, and revenue of $10 million against an anticipated $4.56 million.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.546, "provider_directional_mass": 0.4129, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.488, "sentiment": "neutral", "sentiment_pct": 53, "tone_signals": ["Beat expectations"], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.006964, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 4.9, "age_days": 21.7, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Finance", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "ProQR Therapeutics (Nasdaq:PRQR) - Stock Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxNdUpMMmswRDNqQ240ZzBuaGZndS1MQ2dZODA2Z1JkeFRhanlHclhuelpPSWpCQzVsNEZrRmQtSkFVbHlCQmYycF92YmY1T2hNb2xfWjZWTkFBa0ZEMWpkQk5Uc3hoWGFyMDIxZXp5MHF6YjZJQ1NzV01XdjZkbjQ1R0pJb3BiWk9Gbm1UUHZVTQ?oc=5", "source_link": "https://news.google.com/rss/articles/CBMijwFBVV95cUxNdUpMMmswRDNqQ240ZzBuaGZndS1MQ2dZODA2Z1JkeFRhanlHclhuelpPSWpCQzVsNEZrRmQtSkFVbHlCQmYycF92YmY1T2hNb2xfWjZWTkFBa0ZEMWpkQk5Uc3hoWGFyMDIxZXp5MHF6YjZJQ1NzV01XdjZkbjQ1R0pJb3BiWk9Gbm1UUHZVTQ?oc=5", "source_link_is_lookup": false, "source_name": "Simply Wall Street", "published_at": "2026-09-21T07:00:00+00:00", "published_display": "21 Sep 2026 07:00", "provider": "archive", "providers": ["archive", "google_news"], "provider_symbol": "", "provider_symbols": ["PRQR.ARCHIVE"], "target_provider_symbol": "PRQR.ARCHIVE", "cross_listing": false, "source_names": ["Simply Wall Street"], "source_kind": "publisher", "story_key": "2f3392fad698b901ee45557c00ed737fc690775fb643b629faab01ccd8289c49", "target_scope": "ProQR Therapeutics (Nasdaq:PRQR) - Stock Analysis", "durable_archive": true, "archive_provider": "google_news", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 1.7e-05, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.0, "age_days": 23.7, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": false}], "industry": [], "sector": []}, "total_fetched": 15, "total_unique": 15, "total_relevant": 13, "pipeline_health": {"status": "healthy", "providers_attempted": 4, "providers_with_results": 4, "raw_articles": 52, "unique_stories": 34, "duplicates_removed": 18, "relevant_stories": 13, "matched_archive_stories": 27, "current_evidence": 1, "direct_evidence": 13, "archive_articles": 1, "durable_story_count": 15, "durable_evidence_used": true, "durable_collected_at": "2026-10-09T21:05:46.491821+00:00"}, "sentiment_summary": {"positive": 0, "negative": 1, "neutral": 12, "score": 50, "raw_score": 44, "total": 15, "evidence_count": 1, "effective_articles": 1.0, "information_mass": 0.006, "direct_story_count": 13, "directional_story_count": 1, "direct_source_count": 1, "industry_story_count": 0, "sector_story_count": 0, "story_count": 13, "source_count": 1, "source_concentration": 1.0, "direct_share": 100, "dispersion": 0, "confidence": 16, "evidence_status": "provisional", "score_version": "evidence-v11", "window_days": 30, "weighting_method": "event-aware exponential freshness decay", "newest_article_at": "2026-10-05T05:28:09+00:00", "label": "Early balanced news score", "tone": "neutral"}, "classifier": {"primary_event": "analyst", "primary_label": "Analyst action", "confidence": 77, "events": [{"event": "analyst", "label": "Analyst action", "weight": 3.92, "count": 6}, {"event": "general", "label": "Market update", "weight": 3.0, "count": 5}, {"event": "earnings", "label": "Earnings", "weight": 1.2, "count": 2}], "positive_events": 0, "negative_events": 1, "pipeline": {"status": "healthy", "providers_attempted": 4, "providers_with_results": 4, "raw_articles": 52, "unique_stories": 34, "duplicates_removed": 18, "relevant_stories": 13, "matched_archive_stories": 27, "current_evidence": 1, "direct_evidence": 13, "archive_articles": 1, "durable_story_count": 15, "durable_evidence_used": true, "durable_collected_at": "2026-10-09T21:05:46.491821+00:00"}}, "market_context": {"has_market_context": true, "latest_close": 1.63, "latest_week": "2026-10-09", "one_week_move": -0.3, "four_week_move": -12.4, "twelve_week_move": -4.1, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.29863, "market_dynamics_buy_signal": false, "relative_strength": -23.56415, "fair_value_gap": -19.7, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 47.751, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-0.3% over one week, -12.4% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Early company-news score", "tone": "neutral", "classification": "provisional", "summary": "Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal.", "confidence": 16, "badges": ["Provisional evidence"], "opportunities": [], "risks": [], "event_label": "Analyst action", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "MarketBeat", "count": 5}, {"label": "FinancialContent", "count": 2}, {"label": "Seeking Alpha", "count": 1}, {"label": "Investing.com Nigeria", "count": 1}, {"label": "GuruFocus", "count": 1}, {"label": "TradingView", "count": 1}, {"label": "Stock Titan", "count": 1}, {"label": "Simply Wall Street", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 13}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Analyst action", "count": 6}, {"label": "Market update", "count": 5}, {"label": "Earnings", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Early balanced news score"}, {"label": "Evidence confidence", "value": "16/100", "tone": "neutral", "text": "1.0 effective stories after overlap and weighting."}, {"label": "Market reaction", "value": "Early company-news score", "tone": "neutral", "text": "Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal."}, {"label": "Primary event", "value": "Analyst action", "tone": "neutral", "text": "77/100 evidence concentration around this catalyst."}, {"label": "Company focus", "value": "13", "tone": "positive", "text": "100% of weighted evidence is company-specific."}, {"label": "Evidence agreement", "value": "0/100", "tone": "positive", "text": "lower dispersion means the independent stories agree more closely."}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-0.3% over one week, -12.4% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "FY2028 Earnings Estimate for PRQR Issued By HC Wainwright"}], "updated_at": "2026-10-09T21:05:46.491821+00:00", "detail_intelligence": {"headline": "Early balanced news score", "summary": "13 company-specific stories are available, but there are not yet enough fresh stories from separate publishers for a firm reading.", "status": "provisional", "metrics": [{"label": "News score", "value": 50, "display": "50", "tone": "neutral", "note": "Early balanced news score"}, {"label": "Confidence", "value": 16, "display": "16", "tone": "negative", "note": "thin evidence"}, {"label": "Company news", "value": 100, "display": "100%", "tone": "positive", "note": "13 company stories"}, {"label": "Story agreement", "value": 100, "display": "100", "tone": "positive", "note": "0/100 difference"}], "confidence_drivers": [{"label": "Amount of evidence", "value": 0, "note": "0.006 after freshness weighting"}, {"label": "Source breadth", "value": 20, "note": "1 independent publishers"}, {"label": "Company relevance", "value": 100, "note": "share tied directly to this company"}, {"label": "Freshness", "value": 14, "note": "recency-weighted evidence"}, {"label": "Agreement", "value": 100, "note": "how closely stories agree"}, {"label": "Publisher mix", "value": 0, "note": "less reliance on one publisher"}], "influence": {"events": [{"label": "Analyst action", "positive": 0.0, "negative": 0.006089, "count": 1, "positive_share": 0.0, "positive_width": 0.0, "negative_share": 100.0, "negative_width": 50.0}], "sources": [{"label": "MarketBeat", "weight": 0.006089, "count": 1, "share": 100.0}], "directional_count": 1, "retained_count": 13, "source_count": 1, "top_share": 100.0, "axis_max": 100.0}, "freshness": 14, "source_independence": 0, "timeline": [{"date": "2026-09-15", "label": "15 Sep", "count": 0, "score": null, "tone": "neutral", "x": 42.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-16", "label": "16 Sep", "count": 0, "score": null, "tone": "neutral", "x": 73.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-17", "label": "17 Sep", "count": 0, "score": null, "tone": "neutral", "x": 105.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-18", "label": "18 Sep", "count": 0, "score": null, "tone": "neutral", "x": 136.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-19", "label": "19 Sep", "count": 0, "score": null, "tone": "neutral", "x": 168.3, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-20", "label": "20 Sep", "count": 0, "score": null, "tone": "neutral", "x": 199.9, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-21", "label": "21 Sep", "count": 1, "score": 50, "tone": "neutral", "x": 231.5, "y": 135.0, "volume_height": 13.0, "volume_y": 253.0}, {"date": "2026-09-22", "label": "22 Sep", "count": 0, "score": null, "tone": "neutral", "x": 263.1, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-23", "label": "23 Sep", "count": 2, "score": 53, "tone": "neutral", "x": 294.7, "y": 129.5, "volume_height": 26.0, "volume_y": 240.0}, {"date": "2026-09-24", "label": "24 Sep", "count": 0, "score": null, "tone": "neutral", "x": 326.3, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-25", "label": "25 Sep", "count": 0, "score": null, "tone": "neutral", "x": 357.9, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-26", "label": "26 Sep", "count": 0, "score": null, "tone": "neutral", "x": 389.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-27", "label": "27 Sep", "count": 1, "score": 50, "tone": "neutral", "x": 421.0, "y": 135.0, "volume_height": 13.0, "volume_y": 253.0}, {"date": "2026-09-28", "label": "28 Sep", "count": 0, "score": null, "tone": "neutral", "x": 452.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-29", "label": "29 Sep", "count": 0, "score": null, "tone": "neutral", "x": 484.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-30", "label": "30 Sep", "count": 1, "score": 50, "tone": "neutral", "x": 515.8, "y": 135.0, "volume_height": 13.0, "volume_y": 253.0}, {"date": "2026-10-01", "label": "01 Oct", "count": 4, "score": 48, "tone": "neutral", "x": 547.4, "y": 138.6, "volume_height": 52.0, "volume_y": 214.0}, {"date": "2026-10-02", "label": "02 Oct", "count": 2, "score": 50, "tone": "neutral", "x": 579.0, "y": 135.0, "volume_height": 26.0, "volume_y": 240.0}, {"date": "2026-10-03", "label": "03 Oct", "count": 1, "score": 50, "tone": "neutral", "x": 610.6, "y": 135.0, "volume_height": 13.0, "volume_y": 253.0}, {"date": "2026-10-04", "label": "04 Oct", "count": 0, "score": null, "tone": "neutral", "x": 642.1, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-05", "label": "05 Oct", "count": 1, "score": 46, "tone": "neutral", "x": 673.7, "y": 142.3, "volume_height": 13.0, "volume_y": 253.0}, {"date": "2026-10-06", "label": "06 Oct", "count": 0, "score": null, "tone": "neutral", "x": 705.3, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-07", "label": "07 Oct", "count": 0, "score": null, "tone": "neutral", "x": 736.9, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-08", "label": "08 Oct", "count": 0, "score": null, "tone": "neutral", "x": 768.5, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-09", "label": "09 Oct", "count": 0, "score": null, "tone": "neutral", "x": 800.1, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-10", "label": "10 Oct", "count": 0, "score": null, "tone": "neutral", "x": 831.7, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-11", "label": "11 Oct", "count": 0, "score": null, "tone": "neutral", "x": 863.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-12", "label": "12 Oct", "count": 0, "score": null, "tone": "neutral", "x": 894.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-13", "label": "13 Oct", "count": 0, "score": null, "tone": "neutral", "x": 926.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-14", "label": "14 Oct", "count": 0, "score": null, "tone": "neutral", "x": 958.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}], "timeline_points": "231.5,135.0 294.7,129.5 421.0,135.0 515.8,135.0 547.4,138.6 579.0,135.0 610.6,135.0 673.7,142.3", "timeline_path": "M231.5,135.0 M294.7,129.5 M421.0,135.0 M515.8,135.0 L547.4,138.6 L579.0,135.0 L610.6,135.0 M673.7,142.3", "timeline_has_signal": true, "timeline_start": "15 Sep", "timeline_mid": "30 Sep", "timeline_end": "14 Oct", "momentum": {"label": "Cooling", "tone": "neutral", "recent_score": null, "prior_score": null, "delta": null, "recent_count": 0, "prior_count": 0, "volume_delta": 0, "reliable": false, "reliability_note": "Thin comparison; direction is not yet confirmed"}, "early_change": {"label": "No new story in 24 hours", "tone": "neutral", "latest_score": null, "baseline_score": null, "delta": null, "latest_count": 0, "baseline_count": 0, "confirmed": false, "note": "A comparison needs current and earlier-week company news"}, "freshness_buckets": [{"label": "Last 24 hours", "count": 0, "share": 0}, {"label": "1 to 3 days", "count": 0, "share": 0}, {"label": "4 to 7 days", "count": 0, "share": 0}, {"label": "8 to 14 days", "count": 8, "share": 62}, {"label": "15 to 21 days", "count": 2, "share": 15}, {"label": "22 to 30 days", "count": 3, "share": 23}], "source_profile": [{"label": "MarketBeat", "count": 5, "share": 38, "score": 47, "tone": "neutral"}, {"label": "FinancialContent", "count": 2, "share": 15, "score": 50, "tone": "neutral"}, {"label": "Seeking Alpha", "count": 1, "share": 8, "score": 50, "tone": "neutral"}, {"label": "Investing.com Nigeria", "count": 1, "share": 8, "score": 50, "tone": "neutral"}, {"label": "GuruFocus", "count": 1, "share": 8, "score": 50, "tone": "neutral"}, {"label": "TradingView", "count": 1, "share": 8, "score": 50, "tone": "neutral"}, {"label": "Stock Titan", "count": 1, "share": 8, "score": 50, "tone": "neutral"}], "event_profile": [{"label": "Analyst action", "count": 6, "share": 46, "score": 49, "tone": "neutral"}, {"label": "Market update", "count": 5, "share": 38, "score": 50, "tone": "neutral"}, {"label": "Earnings", "count": 2, "share": 15, "score": 47, "tone": "neutral"}], "topics": [{"label": "Life Sciences", "count": 12, "share": 92}, {"label": "Earnings", "count": 8, "share": 62}, {"label": "Financial Markets", "count": 7, "share": 54}, {"label": "Finance", "count": 3, "share": 23}, {"label": "Technology", "count": 1, "share": 8}], "supporting": [{"label": "Direct evidence", "text": "13 current stories are mapped specifically to PRQR."}], "tempering": [{"label": "Source breadth", "text": "Only 1 publisher currently contribute to the measured read."}, {"label": "Too little evidence", "text": "The stories agree, but freshness-weighted evidence is only 0.006."}, {"label": "Confidence", "text": "Confidence is 16/100, below the threshold for a firm score."}], "supporting_heading": "What supports the score", "tempering_heading": "What limits the score", "latest_observation": {"title": "FY2028 Earnings Estimate for PRQR Issued By HC Wainwright", "summary": "HC Wainwright has revised its FY2028 earnings per share estimate for ProQR Therapeutics (NASDAQ:PRQR) to a loss of $0.37, a reduction from its prior forecast of a $0.27 loss, while maintaining a \"Buy\" rating and an $8.00 price target. The biopharmaceutical company recently reported a narrower-than-expected quarterly loss of $0.09 per share and revenue of $10 million, significantly beating analyst estimates. Analyst sentiment generally remains positive with a \"Moderate Buy\" consensus, and company insiders have recently purchased a substantial amount of shares.", "url": "https://www.marketbeat.com/instant-alerts/estimates-fy2028-earnings-estimate-for-prqr-issued-by-hc-wainwright-2026-10-05", "source_link": "https://www.marketbeat.com/instant-alerts/estimates-fy2028-earnings-estimate-for-prqr-issued-by-hc-wainwright-2026-10-05", "source_link_is_lookup": false, "source_name": "MarketBeat", "published_at": "2026-10-05T05:28:09", "published_display": "05 Oct 2026 05:28", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 46, "tone_signals": ["Negative financial language"], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.037069, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 26.0, "age_days": 9.7, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, "article_count": 13, "updated_at": "2026-10-09T21:05:46.491821+00:00"}, "price_sentiment_path": {"available": true, "price_points": [{"x": 42.0, "y": 113.5, "label": "17 Apr 2026", "close": 1.99, "index": 100.0}, {"x": 78.4, "y": 186.1, "label": "24 Apr 2026", "close": 1.55, "index": 77.9}, {"x": 114.9, "y": 186.1, "label": "01 May 2026", "close": 1.55, "index": 77.9}, {"x": 151.3, "y": 181.1, "label": "08 May 2026", "close": 1.58, "index": 79.4}, {"x": 187.7, "y": 179.5, "label": "15 May 2026", "close": 1.59, "index": 79.9}, {"x": 224.2, "y": 184.4, "label": "22 May 2026", "close": 1.56, "index": 78.4}, {"x": 260.6, "y": 181.1, "label": "29 May 2026", "close": 1.58, "index": 79.4}, {"x": 297.0, "y": 194.3, "label": "05 Jun 2026", "close": 1.5, "index": 75.4}, {"x": 333.5, "y": 204.2, "label": "12 Jun 2026", "close": 1.44, "index": 72.4}, {"x": 369.9, "y": 130.0, "label": "19 Jun 2026", "close": 1.89, "index": 95.0}, {"x": 406.3, "y": 189.4, "label": "26 Jun 2026", "close": 1.53, "index": 76.9}, {"x": 442.8, "y": 143.2, "label": "03 Jul 2026", "close": 1.81, "index": 91.0}, {"x": 479.2, "y": 156.4, "label": "10 Jul 2026", "close": 1.73, "index": 86.9}, {"x": 515.6, "y": 161.3, "label": "17 Jul 2026", "close": 1.7, "index": 85.4}, {"x": 552.0, "y": 158.0, "label": "24 Jul 2026", "close": 1.72, "index": 86.4}, {"x": 588.5, "y": 158.0, "label": "31 Jul 2026", "close": 1.72, "index": 86.4}, {"x": 624.9, "y": 132.5, "label": "07 Aug 2026", "close": 1.875, "index": 94.2}, {"x": 661.3, "y": 125.1, "label": "14 Aug 2026", "close": 1.92, "index": 96.5}, {"x": 697.8, "y": 55.8, "label": "21 Aug 2026", "close": 2.34, "index": 117.6}, {"x": 734.2, "y": 64.1, "label": "28 Aug 2026", "close": 2.29, "index": 115.1}, {"x": 770.6, "y": 100.3, "label": "04 Sep 2026", "close": 2.07, "index": 104.0}, {"x": 807.1, "y": 134.9, "label": "11 Sep 2026", "close": 1.86, "index": 93.5}, {"x": 843.5, "y": 139.9, "label": "18 Sep 2026", "close": 1.83, "index": 92.0}, {"x": 879.9, "y": 169.6, "label": "25 Sep 2026", "close": 1.65, "index": 82.9}, {"x": 916.4, "y": 172.0, "label": "02 Oct 2026", "close": 1.635, "index": 82.2}, {"x": 952.8, "y": 172.9, "label": "09 Oct 2026", "close": 1.63, "index": 81.9}], "sentiment_points": [{"at": "2026-06-26T23:59:59.999Z", "date": "2026-06-26", "label": "26 Jun 2026", "score": 52, "tone": "neutral", "raw_score": 68, "confidence": 29, "stories": 3, "close": 1.53, "price_change": -19.0, "x": 411.5, "y": 126.3, "show_label": true, "label_y": 116.3}, {"at": "2026-07-03T23:59:59.999Z", "date": "2026-07-03", "label": "03 Jul 2026", "score": 51, "tone": "neutral", "raw_score": 57, "confidence": 21, "stories": 9, "close": 1.81, "price_change": 18.3, "x": 448.0, "y": 128.2, "show_label": false, "label_y": 118.19999999999999}, {"at": "2026-07-10T23:59:59.999Z", "date": "2026-07-10", "label": "10 Jul 2026", "score": 50, "tone": "neutral", "raw_score": 57, "confidence": 18, "stories": 11, "close": 1.73, "price_change": -4.4, "x": 484.4, "y": 130.0, "show_label": false, "label_y": 120.0}, {"at": "2026-07-17T23:59:59.999Z", "date": "2026-07-17", "label": "17 Jul 2026", "score": 50, "tone": "neutral", "raw_score": 57, "confidence": 16, "stories": 16, "close": 1.7, "price_change": -1.7, "x": 520.8, "y": 130.0, "show_label": true, "label_y": 120.0}, {"at": "2026-07-24T23:59:59.999Z", "date": "2026-07-24", "label": "24 Jul 2026", "score": 51, "tone": "neutral", "raw_score": 61, "confidence": 21, "stories": 18, "close": 1.72, "price_change": 1.2, "x": 557.2, "y": 128.2, "show_label": false, "label_y": 118.19999999999999}, {"at": "2026-07-31T23:59:59.999Z", "date": "2026-07-31", "label": "31 Jul 2026", "score": 52, "tone": "neutral", "raw_score": 62, "confidence": 26, "stories": 22, "close": 1.72, "price_change": 0.0, "x": 593.7, "y": 126.3, "show_label": false, "label_y": 116.3}, {"at": "2026-08-07T23:59:59.999Z", "date": "2026-08-07", "label": "07 Aug 2026", "score": 52, "tone": "neutral", "raw_score": 59, "confidence": 29, "stories": 25, "close": 1.875, "price_change": 9.0, "x": 630.1, "y": 126.3, "show_label": true, "label_y": 116.3}, {"at": "2026-08-14T23:59:59.999Z", "date": "2026-08-14", "label": "14 Aug 2026", "score": 57, "tone": "neutral", "raw_score": 69, "confidence": 35, "stories": 28, "close": 1.92, "price_change": 2.4, "x": 666.5, "y": 117.1, "show_label": false, "label_y": 107.1}, {"at": "2026-08-21T23:59:59.999Z", "date": "2026-08-21", "label": "21 Aug 2026", "score": 60, "tone": "positive", "raw_score": 72, "confidence": 37, "stories": 33, "close": 2.34, "price_change": 21.9, "x": 703.0, "y": 111.6, "show_label": false, "label_y": 101.6}, {"at": "2026-08-28T23:59:59.999Z", "date": "2026-08-28", "label": "28 Aug 2026", "score": 56, "tone": "neutral", "raw_score": 75, "confidence": 25, "stories": 29, "close": 2.29, "price_change": -2.1, "x": 739.4, "y": 119.0, "show_label": true, "label_y": 109.0}, {"at": "2026-09-04T23:59:59.999Z", "date": "2026-09-04", "label": "04 Sep 2026", "score": 53, "tone": "neutral", "raw_score": 75, "confidence": 19, "stories": 24, "close": 2.07, "price_change": -9.6, "x": 775.8, "y": 124.5, "show_label": false, "label_y": 114.5}, {"at": "2026-09-11T23:59:59.999Z", "date": "2026-09-11", "label": "11 Sep 2026", "score": 51, "tone": "neutral", "raw_score": 76, "confidence": 16, "stories": 26, "close": 1.86, "price_change": -10.1, "x": 812.3, "y": 128.2, "show_label": false, "label_y": 118.19999999999999}, {"at": "2026-09-18T23:59:59.999Z", "date": "2026-09-18", "label": "18 Sep 2026", "score": 50, "tone": "neutral", "raw_score": 79, "confidence": 15, "stories": 17, "close": 1.83, "price_change": -1.6, "x": 848.7, "y": 130.0, "show_label": true, "label_y": 120.0}, {"at": "2026-09-25T23:59:59.999Z", "date": "2026-09-25", "label": "25 Sep 2026", "score": 50, "tone": "neutral", "raw_score": 50, "confidence": 0, "stories": 11, "close": 1.65, "price_change": -9.8, "x": 885.1, "y": 130.0, "show_label": false, "label_y": 120.0}, {"at": "2026-10-02T23:59:59.999Z", "date": "2026-10-02", "label": "02 Oct 2026", "score": 47, "tone": "neutral", "raw_score": 31, "confidence": 29, "stories": 16, "close": 1.635, "price_change": -0.9, "x": 921.6, "y": 135.5, "show_label": false, "label_y": 125.5}, {"at": "2026-10-09T23:59:59.999Z", "date": "2026-10-09", "label": "09 Oct 2026", "score": 49, "tone": "neutral", "raw_score": 31, "confidence": 18, "stories": 15, "close": 1.63, "price_change": -0.3, "x": 958.0, "y": 131.8, "show_label": true, "label_y": 121.80000000000001}], "price_path": "42.0,113.5 78.4,186.1 114.9,186.1 151.3,181.1 187.7,179.5 224.2,184.4 260.6,181.1 297.0,194.3 333.5,204.2 369.9,130.0 406.3,189.4 442.8,143.2 479.2,156.4 515.6,161.3 552.0,158.0 588.5,158.0 624.9,132.5 661.3,125.1 697.8,55.8 734.2,64.1 770.6,100.3 807.1,134.9 843.5,139.9 879.9,169.6 916.4,172.0 952.8,172.9", "sentiment_path": "411.5,126.3 448.0,128.2 484.4,130.0 520.8,130.0 557.2,128.2 593.7,126.3 630.1,126.3 666.5,117.1 703.0,111.6 739.4,119.0 775.8,124.5 812.3,128.2 848.7,130.0 885.1,130.0 921.6,135.5 958.0,131.8", "score_version": "evidence-v11", "price_change": -18.1, "sentiment_change": -3, "recent_pairs": [{"at": "2026-10-09T23:59:59.999Z", "date": "2026-10-09", "label": "09 Oct 2026", "score": 49, "tone": "neutral", "raw_score": 31, "confidence": 18, "stories": 15, "close": 1.63, "price_change": -0.3, "x": 958.0, "y": 131.8, "show_label": true, "label_y": 121.80000000000001}, {"at": "2026-10-02T23:59:59.999Z", "date": "2026-10-02", "label": "02 Oct 2026", "score": 47, "tone": "neutral", "raw_score": 31, "confidence": 29, "stories": 16, "close": 1.635, "price_change": -0.9, "x": 921.6, "y": 135.5, "show_label": false, "label_y": 125.5}, {"at": "2026-09-25T23:59:59.999Z", "date": "2026-09-25", "label": "25 Sep 2026", "score": 50, "tone": "neutral", "raw_score": 50, "confidence": 0, "stories": 11, "close": 1.65, "price_change": -9.8, "x": 885.1, "y": 130.0, "show_label": false, "label_y": 120.0}, {"at": "2026-09-18T23:59:59.999Z", "date": "2026-09-18", "label": "18 Sep 2026", "score": 50, "tone": "neutral", "raw_score": 79, "confidence": 15, "stories": 17, "close": 1.83, "price_change": -1.6, "x": 848.7, "y": 130.0, "show_label": true, "label_y": 120.0}, {"at": "2026-09-11T23:59:59.999Z", "date": "2026-09-11", "label": "11 Sep 2026", "score": 51, "tone": "neutral", "raw_score": 76, "confidence": 16, "stories": 26, "close": 1.86, "price_change": -10.1, "x": 812.3, "y": 128.2, "show_label": false, "label_y": 118.19999999999999}, {"at": "2026-09-04T23:59:59.999Z", "date": "2026-09-04", "label": "04 Sep 2026", "score": 53, "tone": "neutral", "raw_score": 75, "confidence": 19, "stories": 24, "close": 2.07, "price_change": -9.6, "x": 775.8, "y": 124.5, "show_label": false, "label_y": 114.5}, {"at": "2026-08-28T23:59:59.999Z", "date": "2026-08-28", "label": "28 Aug 2026", "score": 56, "tone": "neutral", "raw_score": 75, "confidence": 25, "stories": 29, "close": 2.29, "price_change": -2.1, "x": 739.4, "y": 119.0, "show_label": true, "label_y": 109.0}, {"at": "2026-08-21T23:59:59.999Z", "date": "2026-08-21", "label": "21 Aug 2026", "score": 60, "tone": "positive", "raw_score": 72, "confidence": 37, "stories": 33, "close": 2.34, "price_change": 21.9, "x": 703.0, "y": 111.6, "show_label": false, "label_y": 101.6}], "reconstructed": true, "latest_close": 1.63, "price_observations": 26, "sentiment_observations": 16, "sentiment_start_label": "26 Jun 2026", "sentiment_end_label": "09 Oct 2026", "sentiment_history_limited": false, "price_axis_high": 123.0, "price_axis_mid": 95.0, "price_axis_low": 66.9, "start_label": "17 Apr", "mid_label": "14 Jul", "end_label": "09 Oct", "live_score_version": "evidence-v11", "comparable_to_live": true}, "sentiment_history": [{"label": "22 Jun 23:59", "short_label": "22 Jun", "collected_at": "2026-06-22T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": null, "score_change_display": "Start", "confidence_change": null, "article_change": null, "tone": "neutral", "height": 4, "articles": 1, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true}, {"label": "25 Jun 23:59", "short_label": "25 Jun", "collected_at": "2026-06-25T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 2, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true}, {"label": "26 Jun 23:59", "short_label": "26 Jun", "collected_at": "2026-06-26T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 2, "score_change_display": "+2", "confidence_change": 29, "article_change": 1, "tone": "neutral", "height": 4, "articles": 3, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "27 Jun 23:59", "short_label": "27 Jun", "collected_at": "2026-06-27T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 0, "score_change_display": "+0", "confidence_change": 1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 4, "confidence": 30, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "28 Jun 23:59", "short_label": "28 Jun", "collected_at": "2026-06-28T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": -1, "score_change_display": "-1", "confidence_change": -1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 5, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "30 Jun 23:59", "short_label": "30 Jun", "collected_at": "2026-06-30T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": -4, "article_change": 2, "tone": "neutral", "height": 4, "articles": 7, "confidence": 25, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "02 Jul 23:59", "short_label": "02 Jul", "collected_at": "2026-07-02T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": -3, "article_change": 1, "tone": "neutral", "height": 4, "articles": 8, "confidence": 22, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "03 Jul 23:59", "short_label": "03 Jul", "collected_at": "2026-07-03T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 9, "confidence": 21, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "05 Jul 23:59", "short_label": "05 Jul", "collected_at": "2026-07-05T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": 3, "article_change": 1, "tone": "neutral", "height": 4, "articles": 10, "confidence": 24, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "07 Jul 23:59", "short_label": "07 Jul", "collected_at": "2026-07-07T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": -4, "article_change": 1, "tone": "neutral", "height": 4, "articles": 11, "confidence": 20, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "12 Jul 23:59", "short_label": "12 Jul", "collected_at": "2026-07-12T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": -1, "score_change_display": "-1", "confidence_change": -3, "article_change": 1, "tone": "neutral", "height": 4, "articles": 12, "confidence": 17, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "15 Jul 23:59", "short_label": "15 Jul", "collected_at": "2026-07-15T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": 2, "tone": "neutral", "height": 4, "articles": 14, "confidence": 16, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "16 Jul 23:59", "short_label": "16 Jul", "collected_at": "2026-07-16T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 15, "confidence": 16, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "17 Jul 23:59", "short_label": "17 Jul", "collected_at": "2026-07-17T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 16, "confidence": 16, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "21 Jul 23:59", "short_label": "21 Jul", "collected_at": "2026-07-21T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": 3, "score_change_display": "+3", "confidence_change": 16, "article_change": 3, "tone": "neutral", "height": 6, "articles": 19, "confidence": 32, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "26 Jul 23:59", "short_label": "26 Jul", "collected_at": "2026-07-26T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": -2, "score_change_display": "-2", "confidence_change": -14, "article_change": -2, "tone": "neutral", "height": 4, "articles": 17, "confidence": 18, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "27 Jul 23:59", "short_label": "27 Jul", "collected_at": "2026-07-27T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": -1, "score_change_display": "-1", "confidence_change": -1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 18, "confidence": 17, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "28 Jul 23:59", "short_label": "28 Jul", "collected_at": "2026-07-28T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 1, "score_change_display": "+1", "confidence_change": 12, "article_change": 0, "tone": "neutral", "height": 4, "articles": 18, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "29 Jul 23:59", "short_label": "29 Jul", "collected_at": "2026-07-29T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 1, "score_change_display": "+1", "confidence_change": 1, "article_change": 3, "tone": "neutral", "height": 4, "articles": 21, "confidence": 30, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "30 Jul 23:59", "short_label": "30 Jul", "collected_at": "2026-07-30T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": 1, "tone": "neutral", "height": 4, "articles": 22, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "01 Aug 23:59", "short_label": "01 Aug", "collected_at": "2026-08-01T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": -1, "score_change_display": "-1", "confidence_change": -3, "article_change": 0, "tone": "neutral", "height": 4, "articles": 22, "confidence": 25, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "03 Aug 23:59", "short_label": "03 Aug", "collected_at": "2026-08-03T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": 2, "article_change": 1, "tone": "neutral", "height": 4, "articles": 23, "confidence": 27, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "04 Aug 23:59", "short_label": "04 Aug", "collected_at": "2026-08-04T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 1, "score_change_display": "+1", "confidence_change": 2, "article_change": 0, "tone": "neutral", "height": 4, "articles": 23, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "06 Aug 23:59", "short_label": "06 Aug", "collected_at": "2026-08-06T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": -1, "score_change_display": "-1", "confidence_change": -4, "article_change": 0, "tone": "neutral", "height": 4, "articles": 23, "confidence": 25, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "07 Aug 23:59", "short_label": "07 Aug", "collected_at": "2026-08-07T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 1, "score_change_display": "+1", "confidence_change": 4, "article_change": 2, "tone": "neutral", "height": 4, "articles": 25, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "13 Aug 23:59", "short_label": "13 Aug", "collected_at": "2026-08-13T23:59:59.999999+00:00", "score": 58, "delta": 8, "score_change": 6, "score_change_display": "+6", "confidence_change": 7, "article_change": 2, "tone": "positive", "height": 16, "articles": 27, "confidence": 36, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "14 Aug 23:59", "short_label": "14 Aug", "collected_at": "2026-08-14T23:59:59.999999+00:00", "score": 57, "delta": 7, "score_change": -1, "score_change_display": "-1", "confidence_change": -1, "article_change": 1, "tone": "neutral", "height": 14, "articles": 28, "confidence": 35, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "15 Aug 23:59", "short_label": "15 Aug", "collected_at": "2026-08-15T23:59:59.999999+00:00", "score": 57, "delta": 7, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 0, "tone": "neutral", "height": 14, "articles": 28, "confidence": 35, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "17 Aug 23:59", "short_label": "17 Aug", "collected_at": "2026-08-17T23:59:59.999999+00:00", "score": 55, "delta": 5, "score_change": -2, "score_change_display": "-2", "confidence_change": -5, "article_change": 0, "tone": "neutral", "height": 10, "articles": 28, "confidence": 30, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "18 Aug 23:59", "short_label": "18 Aug", "collected_at": "2026-08-18T23:59:59.999999+00:00", "score": 55, "delta": 5, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": 1, "tone": "neutral", "height": 10, "articles": 29, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "20 Aug 23:59", "short_label": "20 Aug", "collected_at": "2026-08-20T23:59:59.999999+00:00", "score": 61, "delta": 11, "score_change": 6, "score_change_display": "+6", "confidence_change": 13, "article_change": 3, "tone": "positive", "height": 22, "articles": 32, "confidence": 41, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "21 Aug 23:59", "short_label": "21 Aug", "collected_at": "2026-08-21T23:59:59.999999+00:00", "score": 60, "delta": 10, "score_change": -1, "score_change_display": "-1", "confidence_change": -4, "article_change": 1, "tone": "positive", "height": 20, "articles": 33, "confidence": 37, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "22 Aug 23:59", "short_label": "22 Aug", "collected_at": "2026-08-22T23:59:59.999999+00:00", "score": 61, "delta": 11, "score_change": 1, "score_change_display": "+1", "confidence_change": 1, "article_change": 1, "tone": "positive", "height": 22, "articles": 34, "confidence": 38, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true}, {"label": "24 Aug 23:59", "short_label": "24 Aug", "collected_at": "2026-08-24T23:59:59.999999+00:00", "score": 59, "delta": 9, "score_change": -2, "score_change_display": "-2", "confidence_change": -6, "article_change": 1, "tone": "positive", "height": 18, "articles": 35, "confidence": 32, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "28 Aug 23:59", "short_label": "28 Aug", "collected_at": "2026-08-28T23:59:59.999999+00:00", "score": 56, "delta": 6, "score_change": -3, "score_change_display": "-3", "confidence_change": -7, "article_change": -6, "tone": "neutral", "height": 12, "articles": 29, "confidence": 25, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "29 Aug 23:59", "short_label": "29 Aug", "collected_at": "2026-08-29T23:59:59.999999+00:00", "score": 56, "delta": 6, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": -2, "tone": "neutral", "height": 12, "articles": 27, "confidence": 23, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "02 Sep 23:59", "short_label": "02 Sep", "collected_at": "2026-09-02T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": -3, "score_change_display": "-3", "confidence_change": -3, "article_change": -2, "tone": "neutral", "height": 6, "articles": 25, "confidence": 20, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "09 Sep 23:59", "short_label": "09 Sep", "collected_at": "2026-09-09T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": -2, "score_change_display": "-2", "confidence_change": -3, "article_change": -1, "tone": "neutral", "height": 4, "articles": 24, "confidence": 17, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "10 Sep 23:59", "short_label": "10 Sep", "collected_at": "2026-09-10T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 2, "tone": "neutral", "height": 4, "articles": 26, "confidence": 17, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "23 Sep 23:59", "short_label": "23 Sep", "collected_at": "2026-09-23T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": -1, "score_change_display": "-1", "confidence_change": -17, "article_change": -15, "tone": "neutral", "height": 4, "articles": 11, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true}, {"label": "27 Sep 23:59", "short_label": "27 Sep", "collected_at": "2026-09-27T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 0, "tone": "neutral", "height": 4, "articles": 11, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true}, {"label": "30 Sep 23:59", "short_label": "30 Sep", "collected_at": "2026-09-30T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 0, "tone": "neutral", "height": 4, "articles": 11, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true}, {"label": "01 Oct 23:59", "short_label": "01 Oct", "collected_at": "2026-10-01T23:59:59.999999+00:00", "score": 47, "delta": -3, "score_change": -3, "score_change_display": "-3", "confidence_change": 33, "article_change": 4, "tone": "neutral", "height": 6, "articles": 15, "confidence": 33, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "02 Oct 23:59", "short_label": "02 Oct", "collected_at": "2026-10-02T23:59:59.999999+00:00", "score": 47, "delta": -3, "score_change": 0, "score_change_display": "+0", "confidence_change": -4, "article_change": 1, "tone": "neutral", "height": 6, "articles": 16, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "03 Oct 23:59", "short_label": "03 Oct", "collected_at": "2026-10-03T23:59:59.999999+00:00", "score": 48, "delta": -2, "score_change": 1, "score_change_display": "+1", "confidence_change": -3, "article_change": 1, "tone": "neutral", "height": 4, "articles": 17, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "05 Oct 23:59", "short_label": "05 Oct", "collected_at": "2026-10-05T23:59:59.999999+00:00", "score": 48, "delta": -2, "score_change": 0, "score_change_display": "+0", "confidence_change": -4, "article_change": 1, "tone": "neutral", "height": 4, "articles": 18, "confidence": 22, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "14 Oct 22:55", "short_label": "14 Oct", "collected_at": "2026-10-14T22:55:09.918393+00:00", "score": 50, "delta": 0, "score_change": 2, "score_change_display": "+2", "confidence_change": -5, "article_change": -5, "tone": "neutral", "height": 4, "articles": 13, "confidence": 17, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}], "sentiment_history_insight": {"available": true, "series_version": "evidence-v11", "live_version": "evidence-v11", "comparable_to_live": true, "reconstructed": true, "observations": 47, "span_label": "114 days", "first_score": 50, "latest_score": 50, "net_change": 0, "net_change_display": "+0", "direction": "Broadly stable", "high_score": 61, "low_score": 47, "latest_confidence": 17, "confidence_change": 17, "latest_articles": 13, "article_change": 12, "latest_label": "14 Oct 22:55", "latest_evidence_label": "Provisional", "chart_rows": [{"label": "22 Jun 23:59", "short_label": "22 Jun", "collected_at": "2026-06-22T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": null, "score_change_display": "Start", "confidence_change": null, "article_change": null, "tone": "neutral", "height": 4, "articles": 1, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true, "x": 42.0, "y": 135.0}, {"label": "25 Jun 23:59", "short_label": "25 Jun", "collected_at": "2026-06-25T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 2, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true, "x": 61.9, "y": 135.0}, {"label": "26 Jun 23:59", "short_label": "26 Jun", "collected_at": "2026-06-26T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 2, "score_change_display": "+2", "confidence_change": 29, "article_change": 1, "tone": "neutral", "height": 4, "articles": 3, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 81.8, "y": 131.4}, {"label": "27 Jun 23:59", "short_label": "27 Jun", "collected_at": "2026-06-27T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 0, "score_change_display": "+0", "confidence_change": 1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 4, "confidence": 30, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 101.7, "y": 131.4}, {"label": "28 Jun 23:59", "short_label": "28 Jun", "collected_at": "2026-06-28T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": -1, "score_change_display": "-1", "confidence_change": -1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 5, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 121.7, "y": 133.2}, {"label": "30 Jun 23:59", "short_label": "30 Jun", "collected_at": "2026-06-30T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": -4, "article_change": 2, "tone": "neutral", "height": 4, "articles": 7, "confidence": 25, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 141.6, "y": 133.2}, {"label": "02 Jul 23:59", "short_label": "02 Jul", "collected_at": "2026-07-02T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": -3, "article_change": 1, "tone": "neutral", "height": 4, "articles": 8, "confidence": 22, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 161.5, "y": 133.2}, {"label": "03 Jul 23:59", "short_label": "03 Jul", "collected_at": "2026-07-03T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 9, "confidence": 21, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 181.4, "y": 133.2}, {"label": "05 Jul 23:59", "short_label": "05 Jul", "collected_at": "2026-07-05T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": 3, "article_change": 1, "tone": "neutral", "height": 4, "articles": 10, "confidence": 24, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 201.3, "y": 133.2}, {"label": "07 Jul 23:59", "short_label": "07 Jul", "collected_at": "2026-07-07T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": -4, "article_change": 1, "tone": "neutral", "height": 4, "articles": 11, "confidence": 20, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 221.2, "y": 133.2}, {"label": "12 Jul 23:59", "short_label": "12 Jul", "collected_at": "2026-07-12T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": -1, "score_change_display": "-1", "confidence_change": -3, "article_change": 1, "tone": "neutral", "height": 4, "articles": 12, "confidence": 17, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 241.1, "y": 135.0}, {"label": "15 Jul 23:59", "short_label": "15 Jul", "collected_at": "2026-07-15T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": 2, "tone": "neutral", "height": 4, "articles": 14, "confidence": 16, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 261.0, "y": 135.0}, {"label": "16 Jul 23:59", "short_label": "16 Jul", "collected_at": "2026-07-16T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 15, "confidence": 16, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 281.0, "y": 135.0}, {"label": "17 Jul 23:59", "short_label": "17 Jul", "collected_at": "2026-07-17T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 16, "confidence": 16, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 300.9, "y": 135.0}, {"label": "21 Jul 23:59", "short_label": "21 Jul", "collected_at": "2026-07-21T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": 3, "score_change_display": "+3", "confidence_change": 16, "article_change": 3, "tone": "neutral", "height": 6, "articles": 19, "confidence": 32, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 320.8, "y": 129.5}, {"label": "26 Jul 23:59", "short_label": "26 Jul", "collected_at": "2026-07-26T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": -2, "score_change_display": "-2", "confidence_change": -14, "article_change": -2, "tone": "neutral", "height": 4, "articles": 17, "confidence": 18, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 340.7, "y": 133.2}, {"label": "27 Jul 23:59", "short_label": "27 Jul", "collected_at": "2026-07-27T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": -1, "score_change_display": "-1", "confidence_change": -1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 18, "confidence": 17, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 360.6, "y": 135.0}, {"label": "28 Jul 23:59", "short_label": "28 Jul", "collected_at": "2026-07-28T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 1, "score_change_display": "+1", "confidence_change": 12, "article_change": 0, "tone": "neutral", "height": 4, "articles": 18, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 380.5, "y": 133.2}, {"label": "29 Jul 23:59", "short_label": "29 Jul", "collected_at": "2026-07-29T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 1, "score_change_display": "+1", "confidence_change": 1, "article_change": 3, "tone": "neutral", "height": 4, "articles": 21, "confidence": 30, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 400.4, "y": 131.4}, {"label": "30 Jul 23:59", "short_label": "30 Jul", "collected_at": "2026-07-30T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": 1, "tone": "neutral", "height": 4, "articles": 22, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 420.3, "y": 131.4}, {"label": "01 Aug 23:59", "short_label": "01 Aug", "collected_at": "2026-08-01T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": -1, "score_change_display": "-1", "confidence_change": -3, "article_change": 0, "tone": "neutral", "height": 4, "articles": 22, "confidence": 25, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 440.3, "y": 133.2}, {"label": "03 Aug 23:59", "short_label": "03 Aug", "collected_at": "2026-08-03T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": 2, "article_change": 1, "tone": "neutral", "height": 4, "articles": 23, "confidence": 27, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 460.2, "y": 133.2}, {"label": "04 Aug 23:59", "short_label": "04 Aug", "collected_at": "2026-08-04T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 1, "score_change_display": "+1", "confidence_change": 2, "article_change": 0, "tone": "neutral", "height": 4, "articles": 23, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 480.1, "y": 131.4}, {"label": "06 Aug 23:59", "short_label": "06 Aug", "collected_at": "2026-08-06T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": -1, "score_change_display": "-1", "confidence_change": -4, "article_change": 0, "tone": "neutral", "height": 4, "articles": 23, "confidence": 25, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 500.0, "y": 133.2}, {"label": "07 Aug 23:59", "short_label": "07 Aug", "collected_at": "2026-08-07T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 1, "score_change_display": "+1", "confidence_change": 4, "article_change": 2, "tone": "neutral", "height": 4, "articles": 25, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 519.9, "y": 131.4}, {"label": "13 Aug 23:59", "short_label": "13 Aug", "collected_at": "2026-08-13T23:59:59.999999+00:00", "score": 58, "delta": 8, "score_change": 6, "score_change_display": "+6", "confidence_change": 7, "article_change": 2, "tone": "positive", "height": 16, "articles": 27, "confidence": 36, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 539.8, "y": 120.4}, {"label": "14 Aug 23:59", "short_label": "14 Aug", "collected_at": "2026-08-14T23:59:59.999999+00:00", "score": 57, "delta": 7, "score_change": -1, "score_change_display": "-1", "confidence_change": -1, "article_change": 1, "tone": "neutral", "height": 14, "articles": 28, "confidence": 35, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 559.7, "y": 122.3}, {"label": "15 Aug 23:59", "short_label": "15 Aug", "collected_at": "2026-08-15T23:59:59.999999+00:00", "score": 57, "delta": 7, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 0, "tone": "neutral", "height": 14, "articles": 28, "confidence": 35, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 579.7, "y": 122.3}, {"label": "17 Aug 23:59", "short_label": "17 Aug", "collected_at": "2026-08-17T23:59:59.999999+00:00", "score": 55, "delta": 5, "score_change": -2, "score_change_display": "-2", "confidence_change": -5, "article_change": 0, "tone": "neutral", "height": 10, "articles": 28, "confidence": 30, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 599.6, "y": 125.9}, {"label": "18 Aug 23:59", "short_label": "18 Aug", "collected_at": "2026-08-18T23:59:59.999999+00:00", "score": 55, "delta": 5, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": 1, "tone": "neutral", "height": 10, "articles": 29, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 619.5, "y": 125.9}, {"label": "20 Aug 23:59", "short_label": "20 Aug", "collected_at": "2026-08-20T23:59:59.999999+00:00", "score": 61, "delta": 11, "score_change": 6, "score_change_display": "+6", "confidence_change": 13, "article_change": 3, "tone": "positive", "height": 22, "articles": 32, "confidence": 41, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true, "x": 639.4, "y": 115.0}, {"label": "21 Aug 23:59", "short_label": "21 Aug", "collected_at": "2026-08-21T23:59:59.999999+00:00", "score": 60, "delta": 10, "score_change": -1, "score_change_display": "-1", "confidence_change": -4, "article_change": 1, "tone": "positive", "height": 20, "articles": 33, "confidence": 37, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true, "x": 659.3, "y": 116.8}, {"label": "22 Aug 23:59", "short_label": "22 Aug", "collected_at": "2026-08-22T23:59:59.999999+00:00", "score": 61, "delta": 11, "score_change": 1, "score_change_display": "+1", "confidence_change": 1, "article_change": 1, "tone": "positive", "height": 22, "articles": 34, "confidence": 38, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "reconstructed": true, "x": 679.2, "y": 115.0}, {"label": "24 Aug 23:59", "short_label": "24 Aug", "collected_at": "2026-08-24T23:59:59.999999+00:00", "score": 59, "delta": 9, "score_change": -2, "score_change_display": "-2", "confidence_change": -6, "article_change": 1, "tone": "positive", "height": 18, "articles": 35, "confidence": 32, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 699.1, "y": 118.6}, {"label": "28 Aug 23:59", "short_label": "28 Aug", "collected_at": "2026-08-28T23:59:59.999999+00:00", "score": 56, "delta": 6, "score_change": -3, "score_change_display": "-3", "confidence_change": -7, "article_change": -6, "tone": "neutral", "height": 12, "articles": 29, "confidence": 25, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 719.0, "y": 124.1}, {"label": "29 Aug 23:59", "short_label": "29 Aug", "collected_at": "2026-08-29T23:59:59.999999+00:00", "score": 56, "delta": 6, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": -2, "tone": "neutral", "height": 12, "articles": 27, "confidence": 23, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 739.0, "y": 124.1}, {"label": "02 Sep 23:59", "short_label": "02 Sep", "collected_at": "2026-09-02T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": -3, "score_change_display": "-3", "confidence_change": -3, "article_change": -2, "tone": "neutral", "height": 6, "articles": 25, "confidence": 20, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 758.9, "y": 129.5}, {"label": "09 Sep 23:59", "short_label": "09 Sep", "collected_at": "2026-09-09T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": -2, "score_change_display": "-2", "confidence_change": -3, "article_change": -1, "tone": "neutral", "height": 4, "articles": 24, "confidence": 17, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 778.8, "y": 133.2}, {"label": "10 Sep 23:59", "short_label": "10 Sep", "collected_at": "2026-09-10T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 2, "tone": "neutral", "height": 4, "articles": 26, "confidence": 17, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 798.7, "y": 133.2}, {"label": "23 Sep 23:59", "short_label": "23 Sep", "collected_at": "2026-09-23T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": -1, "score_change_display": "-1", "confidence_change": -17, "article_change": -15, "tone": "neutral", "height": 4, "articles": 11, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true, "x": 818.6, "y": 135.0}, {"label": "27 Sep 23:59", "short_label": "27 Sep", "collected_at": "2026-09-27T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 0, "tone": "neutral", "height": 4, "articles": 11, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true, "x": 838.5, "y": 135.0}, {"label": "30 Sep 23:59", "short_label": "30 Sep", "collected_at": "2026-09-30T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 0, "tone": "neutral", "height": 4, "articles": 11, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true, "x": 858.4, "y": 135.0}, {"label": "01 Oct 23:59", "short_label": "01 Oct", "collected_at": "2026-10-01T23:59:59.999999+00:00", "score": 47, "delta": -3, "score_change": -3, "score_change_display": "-3", "confidence_change": 33, "article_change": 4, "tone": "neutral", "height": 6, "articles": 15, "confidence": 33, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 878.3, "y": 140.5}, {"label": "02 Oct 23:59", "short_label": "02 Oct", "collected_at": "2026-10-02T23:59:59.999999+00:00", "score": 47, "delta": -3, "score_change": 0, "score_change_display": "+0", "confidence_change": -4, "article_change": 1, "tone": "neutral", "height": 6, "articles": 16, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 898.3, "y": 140.5}, {"label": "03 Oct 23:59", "short_label": "03 Oct", "collected_at": "2026-10-03T23:59:59.999999+00:00", "score": 48, "delta": -2, "score_change": 1, "score_change_display": "+1", "confidence_change": -3, "article_change": 1, "tone": "neutral", "height": 4, "articles": 17, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 918.2, "y": 138.6}, {"label": "05 Oct 23:59", "short_label": "05 Oct", "collected_at": "2026-10-05T23:59:59.999999+00:00", "score": 48, "delta": -2, "score_change": 0, "score_change_display": "+0", "confidence_change": -4, "article_change": 1, "tone": "neutral", "height": 4, "articles": 18, "confidence": 22, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 938.1, "y": 138.6}, {"label": "14 Oct 22:55", "short_label": "14 Oct", "collected_at": "2026-10-14T22:55:09.918393+00:00", "score": 50, "delta": 0, "score_change": 2, "score_change_display": "+2", "confidence_change": -5, "article_change": -5, "tone": "neutral", "height": 4, "articles": 13, "confidence": 17, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 958.0, "y": 135.0}], "chart_points": "42.0,135.0 61.9,135.0 81.8,131.4 101.7,131.4 121.7,133.2 141.6,133.2 161.5,133.2 181.4,133.2 201.3,133.2 221.2,133.2 241.1,135.0 261.0,135.0 281.0,135.0 300.9,135.0 320.8,129.5 340.7,133.2 360.6,135.0 380.5,133.2 400.4,131.4 420.3,131.4 440.3,133.2 460.2,133.2 480.1,131.4 500.0,133.2 519.9,131.4 539.8,120.4 559.7,122.3 579.7,122.3 599.6,125.9 619.5,125.9 639.4,115.0 659.3,116.8 679.2,115.0 699.1,118.6 719.0,124.1 739.0,124.1 758.9,129.5 778.8,133.2 798.7,133.2 818.6,135.0 838.5,135.0 858.4,135.0 878.3,140.5 898.3,140.5 918.2,138.6 938.1,138.6 958.0,135.0", "changes": [{"label": "14 Oct 22:55", "short_label": "14 Oct", "collected_at": "2026-10-14T22:55:09.918393+00:00", "score": 50, "delta": 0, "score_change": 2, "score_change_display": "+2", "confidence_change": -5, "article_change": -5, "tone": "neutral", "height": 4, "articles": 13, "confidence": 17, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "05 Oct 23:59", "short_label": "05 Oct", "collected_at": "2026-10-05T23:59:59.999999+00:00", "score": 48, "delta": -2, "score_change": 0, "score_change_display": "+0", "confidence_change": -4, "article_change": 1, "tone": "neutral", "height": 4, "articles": 18, "confidence": 22, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "03 Oct 23:59", "short_label": "03 Oct", "collected_at": "2026-10-03T23:59:59.999999+00:00", "score": 48, "delta": -2, "score_change": 1, "score_change_display": "+1", "confidence_change": -3, "article_change": 1, "tone": "neutral", "height": 4, "articles": 17, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "02 Oct 23:59", "short_label": "02 Oct", "collected_at": "2026-10-02T23:59:59.999999+00:00", "score": 47, "delta": -3, "score_change": 0, "score_change_display": "+0", "confidence_change": -4, "article_change": 1, "tone": "neutral", "height": 6, "articles": 16, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "01 Oct 23:59", "short_label": "01 Oct", "collected_at": "2026-10-01T23:59:59.999999+00:00", "score": 47, "delta": -3, "score_change": -3, "score_change_display": "-3", "confidence_change": 33, "article_change": 4, "tone": "neutral", "height": 6, "articles": 15, "confidence": 33, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "30 Sep 23:59", "short_label": "30 Sep", "collected_at": "2026-09-30T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 0, "tone": "neutral", "height": 4, "articles": 11, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true}, {"label": "27 Sep 23:59", "short_label": "27 Sep", "collected_at": "2026-09-27T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 0, "tone": "neutral", "height": 4, "articles": 11, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true}, {"label": "23 Sep 23:59", "short_label": "23 Sep", "collected_at": "2026-09-23T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": -1, "score_change_display": "-1", "confidence_change": -17, "article_change": -15, "tone": "neutral", "height": 4, "articles": 11, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true}]}, "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}